Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 11Observational 1

Sponsor

Cancer Type

Dermatologic 38Thoracic 3Genitourinary 3Gastrointestinal 3Other solid neoplasm 2Lymphoid 2Sarcoma 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Ovarian Neoplasms 586Uterine Cervical Neoplasms 497Endometrial Neoplasms 319Breast Neoplasms 140Uterine Cervical Dysplasia 103Neoplasms 102Carcinoma, Ovarian Epithelial 90Fallopian Tube Neoplasms 78Lung Neoplasms 65Colorectal Neoplasms 64Uterine Neoplasms 61Vulvar Neoplasms 56Pancreatic Neoplasms 56Papillomavirus Infections 53Prostatic Neoplasms 52Stomach Neoplasms 49Colonic Neoplasms 47Peritoneal Neoplasms 41Melanoma 39Urinary Bladder Neoplasms 37Carcinoma, Non-Small-Cell Lung 37Esophageal Neoplasms 36Head and Neck Neoplasms 32Pelvic Neoplasms 29Vaginal Neoplasms 28Recurrence 28Rectal Neoplasms 27Ovarian Cysts 27Endometrial Hyperplasia 26Sarcoma 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Uveal Melanoma × Gynecologic × Clear all
NCT05812027 2025-11-17

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

TScan Therapeutics, Inc.

Active not recruiting
1,150 enrolled
DermatologicGynecologicHead & NeckSarcomaThoracic

Uveal Melanoma, Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡